5M01 RR00036/RR/NCRR NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1998	2
1999	1
2002	2
2005	1
2006	2
2007	1
2024	0

1

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia.

Newcomer JW, Haupt DW, Fucetola R, Melson AK, Schweiger JA, Cooper BP, Selke G. Newcomer JW, et al. Arch Gen Psychiatry. 2002 Apr;59(4):337-45. doi: 10.1001/archpsyc.59.4.337. Arch Gen Psychiatry. 2002. PMID: 11926934 Review.

2

Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans.

Newcomer JW, Selke G, Melson AK, Gross J, Vogler GP, Dagogo-Jack S. Newcomer JW, et al. Arch Gen Psychiatry. 1998 Nov;55(11):995-1000. doi: 10.1001/archpsyc.55.11.995. Arch Gen Psychiatry. 1998. PMID: 9819068 Clinical Trial.

3

Glucocorticoid interactions with memory function in schizophrenia.

Newcomer JW, Craft S, Askins K, Hershey T, Bardgett ME, Csernansky JG, Gagliardi AE, Vogler G. Newcomer JW, et al. Psychoneuroendocrinology. 1998 Jan;23(1):65-72. doi: 10.1016/s0306-4530(97)00081-4. Psychoneuroendocrinology. 1998. PMID: 9618753 Free article. Clinical Trial.

4

Abnormalities in glucose regulation associated with mental illness and treatment.

Haupt DW, Newcomer JW. Haupt DW, et al. J Psychosom Res. 2002 Oct;53(4):925-33. doi: 10.1016/s0022-3999(02)00471-3. J Psychosom Res. 2002. PMID: 12377305 Review. No abstract available.

5

IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction.

Mikols CL, Yan L, Norris JY, Russell TD, Khalifah AP, Hachem RR, Chakinala MM, Yusen RD, Castro M, Kuo E, Patterson GA, Mohanakumar T, Trulock EP, Walter MJ. Mikols CL, et al. Am J Respir Crit Care Med. 2006 Aug 15;174(4):461-70. doi: 10.1164/rccm.200512-1886OC. Epub 2006 May 25. Am J Respir Crit Care Med. 2006. PMID: 16728708 Free PMC article.

6

Age- and dose-dependent glucose-induced increases in memory and attention in schizophrenia.

Fucetola R, Newcomer JW, Craft S, Melson AK. Fucetola R, et al. Psychiatry Res. 1999 Oct 18;88(1):1-13. doi: 10.1016/s0165-1781(99)00063-3. Psychiatry Res. 1999. PMID: 10641582 Clinical Trial.

7

Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus.

Israelian Z, Szoke E, Woerle J, Bokhari S, Schorr M, Schwenke DC, Cryer PE, Gerich JE, Meyer C. Israelian Z, et al. Metabolism. 2006 May;55(5):593-8. doi: 10.1016/j.metabol.2005.11.013. Metabolism. 2006. PMID: 16631434

8

Adiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patients.

Haupt DW, Fahnestock PA, Flavin KA, Schweiger JA, Stevens A, Hessler MJ, Maeda J, Yingling M, Newcomer JW. Haupt DW, et al. Neuropsychopharmacology. 2007 Dec;32(12):2561-9. doi: 10.1038/sj.npp.1301392. Epub 2007 Mar 21. Neuropsychopharmacology. 2007. PMID: 17375138

9

Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes.

Israelian Z, Gosmanov NR, Szoke E, Schorr M, Bokhari S, Cryer PE, Gerich JE, Meyer C. Israelian Z, et al. Diabetes Care. 2005 Nov;28(11):2691-6. doi: 10.2337/diacare.28.11.2691. Diabetes Care. 2005. PMID: 16249541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year